| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = $13,039,205 ) (Continued on the next page) |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 001 | 4 | NIH | 3/24/2025 | $150,000 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 001 | 4 | NIH | 3/24/2025 | $1 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL167656 | Cardiovascular Risk of Antiretroviral Therapy Drugs in HIV | 001 | 3 | NIH | 5/5/2025 | $65,402 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL167656 | Cardiovascular Risk of Antiretroviral Therapy Drugs in HIV | 000 | 3 | NIH | 3/31/2025 | $588,613 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01EY034946 | Retinal Pigmented Epithelium Epigenome Dysregulation With Aging and Modulation by Diet | 000 | 2 | NIH | 1/23/2025 | $536,749 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | U01AI176244 | Autoimmune Drivers and Protectors Team Science (ADAPTS) | 000 | 3 | NIH | 1/23/2025 | $1,249,430 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG081855 | Mitochondrial NAD+ Metabolism in Cardiac Aging | 000 | 2 | NIH | 12/24/2024 | $539,182 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DA060226 | Effects of tobacco smoking on prognosis and immune function in multiple sclerosis | 000 | 1 | NIH | 5/16/2025 | $552,147 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01EY033782 | Interrogating the intersection between diet and ocular autoimmunity | 000 | 4 | NIH | 4/3/2025 | $541,165 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG074502 | Determining the context specificity of metformin treatment on muscle mitochondria and healthspan | 001 | 4 | NIH | 12/19/2024 | $0 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG074502 | Determining the context specificity of metformin treatment on muscle mitochondria and healthspan | 000 | 4 | NIH | 12/18/2024 | $536,527 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG070035 | Role of estrogen receptor-a in aging and sex-specific responses to 17a-estradiol | 000 | 5 | NIH | 5/7/2025 | $463,921 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | K01AR077684 | The role of Fbxl22 in the regulation of skeletal muscle mass | 000 | 5 | NIH | 5/7/2025 | $120,420 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI156724 | Disease and Race Specific Single-cell Epigenetic Mechanisms in Human SLE | 000 | 5 | NIH | 4/16/2025 | $760,427 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01NS135830 | Influence of neuromelanin on single dopaminergic neurons in Parkinson's disease. | 000 | 1 | NIH | 1/23/2025 | $616,200 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL131652 | Defining the Mechanisms of Lymphatic Vascular Growth and Function | 000 | 8 | NIH | 11/6/2024 | $474,299 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM149343 | Mechanisms of cohesin regulation in vertebrates | 001 | 3 | NIH | 4/2/2025 | $426,250 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI183676 | Defining the Regulatory Landscape of Lupus with CVD Comorbidity | 000 | 1 | NIH | 11/20/2024 | $793,093 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HL163095 | Novel lymphatic genes that regulate heart valve development and disease | 000 | 3 | NIH | 11/18/2024 | $480,910 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | K99AG086524 | Investigating TFEB as a critical node to improve proteostatic maintenance and skeletal muscle function with age | 000 | 1 | NIH | 11/22/2024 | $135,057 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01DE032911 | Aging and Oxidative Stress Influence Salivary Gland Disease in Sjogren's Syndrome | 000 | 3 | NIH | 3/5/2025 | $457,299 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35HL145237 | Translational Control of Megakaryocyte and Platelet Gene Expression in Disease | 000 | 7 | NIH | 1/20/2025 | $641,012 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UM1AI144292 | Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail Success | 002 | 7 | NIH | 5/6/2025 | $767,250 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HD110990 | Development of a lacO/lacI based fluorescence reporter-operator system to study chromosome dynamics and double-strand break repair in mouse meiosis. | 001 | 3 | NIH | 4/25/2025 | $36,657 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01HD110990 | Development of a lacO/lacI based fluorescence reporter-operator system to study chromosome dynamics and double-strand break repair in mouse meiosis. | 000 | 3 | NIH | 2/13/2025 | $329,918 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | F32AR083823 | Deciphering the myofibroblast life cycle in skin wound healing | 000 | 2 | NIH | 3/17/2025 | $79,756 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21AR084235 | MuRF1 substrates and mechanisms of skeletal muscle atrophy | 001 | 2 | NIH | 4/29/2025 | $13,129 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R21AR084235 | MuRF1 substrates and mechanisms of skeletal muscle atrophy | 000 | 2 | NIH | 3/3/2025 | $168,795 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM152165 | Centromere behaviors that promote proper chromosome segregation in meiosis and mitosis | 001 | 2 | NIH | 12/10/2024 | $383,625 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AR080896 | PDGFRB Signaling in Progressive Skin Disease | 000 | 3 | NIH | 1/23/2025 | $476,629 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI168355 | Complement C5 inhibition as sepsis therapy | 000 | 4 | NIH | 3/21/2025 | $633,416 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 001 | 4 | NIH | 3/24/2025 | $100,000 |
| | 2025 | 2025 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 002 | 4 | NIH | 3/31/2025 | $1 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 3 | NIH | 11/1/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AI178947 | γδTCR-dependent and independent differentiation of innate lymphoid cells | 000 | 2 | NIH | 4/18/2025 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM126980 | Understanding Cell Division | 002 | 6 | NIH | 3/24/2025 | $14,585 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM126980 | Understanding Cell Division | 000 | 6 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM149343 | Mechanisms of cohesin regulation in vertebrates | 000 | 2 | NIH | 11/5/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UM1AI144292 | Oklahoma ACE: Molecular Destruction of Autoimmune Disease to Aid Clinical Trail Success | 001 | 6 | NIH | 2/19/2025 | $20,984 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R01AG064951 | Does insulin sensitivity impact the potential of metformin to slow aging? | 000 | 5 | NIH | 3/4/2025 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM152165 | Centromere behaviors that promote proper chromosome segregation in meiosis and mitosis | 000 | 1 | NIH | 11/21/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 3 | NIH | 11/1/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 3 | NIH | 11/1/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 3 | NIH | 11/1/2024 | $0 |
| | 2025 | 2024 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | UC2AR081032 | Accelerating Medicines Partnership-Autoimmune and Immunologic Disease Tissue Research Core | 000 | 3 | NIH | 11/1/2024 | $0 |
| | 2025 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R13AG059431 | Summer Training Course in Experimental Aging | 001 | 6 | NIH | 5/12/2025 | -$54,068 |
| | 2025 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | U01AG055133 | MoTrPAC: UC Preclinical Animal Study Site - Supplement | 000 | 7 | NIH | 4/7/2025 | -$23,067 |
| | 2025 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | CE152464 | Community Project Funding/Congressionally Directed Spending - Construction | 03 | 1 | HRSA | 12/19/2024 | $0 |
| | 2025 | 2023 | OKLAHOMA MEDICAL RESEARCH FOUNDATION | 825 NE 13TH ST | OKLAHOMA CITY | OK | 73104-5005 | OKLAHOMA | USA | R35GM142726 | Mechanisms of APP ectodomain function | 001 | 4 | NIH | 1/20/2025 | $3,464 |
|
